mBio

Medications

Drug targeting Ebola virus protein VP24 shows promise in monkeys

An experimental medication that targets a protein in Ebola virus called VP24 protected 75% of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the U.S. Army, in collaboration ...

Medical research

New type of antibiotic resistance living in hiding

Aggressive infections constitute an increasing health problem all over the world. The development of bacterial resistance development is immense, and in the USA, resistant staphylococci cause more deaths than AIDS on an annual ...

Diseases, Conditions, Syndromes

Some flu viruses potentially more dangerous than others

Certain subtypes of avian influenza viruses have the potential to cause more severe disease in humans than other avian influenza subtypes and should be monitored carefully to prevent spread of disease, according to a study ...

Diseases, Conditions, Syndromes

Ebola, Marburg viruses edit genetic material during infection

Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio®, the online open-access journal of the American Society for Microbiology. The work, by researchers ...

Diseases, Conditions, Syndromes

Rats of New York and the diseases they carry

In the first study to look at would-be diseases carried by New York City rats, scientists at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified bacterial pathogens, including ...

page 24 from 27